EPISODE · Apr 7, 2026 · 26 MIN
Mounjaro vs Ozempic — Which One Works Better? - One Hormone vs Two: Why Tirzepatide Wins
from Mounjaro vs Ozempic — Which One Works Better? · host Inception Point AI
Ben Synth explores why Mounjaro outperforms Ozempic for weight loss by activating two gut hormones instead of one. Drawing on SURMOUNT-5 trial data showing 20% versus 14% weight loss, he traces GIP's journey from forgotten molecule to metabolic game-changer, revealing how dual-receptor targeting creates synergistic effects that reshape obesity pharmacology's future. Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV This content was created in partnership and with the help of Artificial Intelligence AI.
Embed this episode
NOW PLAYING
Mounjaro vs Ozempic — Which One Works Better? - One Hormone vs Two: Why Tirzepatide Wins
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.